{"id":4883,"date":"2019-10-09T13:00:33","date_gmt":"2019-10-09T11:00:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/"},"modified":"2019-10-09T13:00:33","modified_gmt":"2019-10-09T11:00:33","slug":"sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/","title":{"rendered":"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019"},"content":{"rendered":"
\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage<\/a> #SageRx<\/a>–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and discuss recent business updates.\n<\/p>\n

<\/a><\/p>\n

\nThe webcast can be accessed on the investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.\n<\/p>\n

\nAbout Sage Therapeutics
\n
<\/b>Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com<\/a>.\n<\/p>\n

\"\"<\/span><\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact<\/b>
Matt Calistri
\n
617-914-2635
\n
matthew.calistri@sagerx.com<\/a><\/p>\n

Media Contact<\/b>
Alexis Smith
\n
617-588-3740
\n
alexis.smith@sagerx.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage #SageRx–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-4883","6":"format-standard","7":"category-allgemein"},"yoast_head":"\nSage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage #SageRx–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-09T11:00:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20191009005052\/en\/736779\/21\/Sage_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019\",\"datePublished\":\"2019-10-09T11:00:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/\"},\"wordCount\":217,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005052\\\/en\\\/736779\\\/21\\\/Sage_logo.jpg\",\"articleSection\":[\"Allgemein\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/\",\"name\":\"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005052\\\/en\\\/736779\\\/21\\\/Sage_logo.jpg\",\"datePublished\":\"2019-10-09T11:00:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005052\\\/en\\\/736779\\\/21\\\/Sage_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20191009005052\\\/en\\\/736779\\\/21\\\/Sage_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/","og_locale":"en_US","og_type":"article","og_title":"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 - Pharma Trend","og_description":"CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage #SageRx–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/","og_site_name":"Pharma Trend","article_published_time":"2019-10-09T11:00:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20191009005052\/en\/736779\/21\/Sage_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019","datePublished":"2019-10-09T11:00:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/"},"wordCount":217,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20191009005052\/en\/736779\/21\/Sage_logo.jpg","articleSection":["Allgemein"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/","url":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/","name":"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20191009005052\/en\/736779\/21\/Sage_logo.jpg","datePublished":"2019-10-09T11:00:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20191009005052\/en\/736779\/21\/Sage_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20191009005052\/en\/736779\/21\/Sage_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sage-therapeutics-to-report-third-quarter-2019-financial-results-on-tuesday-november-12-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/4883","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=4883"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/4883\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=4883"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=4883"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=4883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}